A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2017

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Opioid-Related DisordersPain, AcutePain, Postoperative
Interventions
DRUG

GRT7014 - Abuse Deterrend Tablet

Single oral dose in one of the four cross-over trial periods and in the standard cross-over trial periods.

DRUG

Norco 5Mg-325Mg Tablet

Single oral dose in one of the four cross-over trial periods and in the standard cross-over trial periods.

Trial Locations (1)

66219

US001: PRA Health Sciences, Lenexa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Grünenthal GmbH

INDUSTRY

NCT03137030 - A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults | Biotech Hunter | Biotech Hunter